Peckia chrysostoma obtained mean viability of 97.0±2.4% for larvae and of 96.9±2.5% for pupae (total viability of 94.0±3.7%). Adiscochaeta ingens obtained mean viability of 93.0±7.5% for larvae and of 92.8±7.6% for pupae (total viability of 86.0±7.3%). P. chrysostoma obtained mean larval period of 185±4 hr at 18ºC, of 94±2 hr at 27ºC and of 88±2 hr at room temperature (range of 23ºC and 29ºC). A. ingens obtained mean larval period of 169±1 hr at 18ºC, of 77±1 hr at 27ºC and of 84±2hr at room temperature. P. chrysostoma obtained mean pupal period of 23.5±1.3 days at 18ºC, of 12.5±0.7 days at 27ºC and of 15.5±0.7 days at room temperature. A. ingens obtained mean pupal period of 33.0±2.2 days at 18ºC, of 16.0±1.0 days at 27ºC and of 19.0±1.0 days at room temperature
Groups of 10 and 20 first instar larvae of Peckia chrysostoma (Wiedemann, 1830) were combined in a proteic source media with groups of the same number of first instar larvae of Adiscochaeta ingens (Walker, 1849) under the environmental conditions of Rio de Janeiro, RJ, Brasil. P. chrysostoma and A. ingens obtained average competitive potentials of 94.0 ± 2.0% and 31.0 ± 5.0% respectively. In the second experiment, larvae of P. chrysostoma were introduced approximately 15 hr after the introduction of A. ingens larvae (whose majority had already passed to the second instar) in the media. The corresponding average competitive potential of P. chrysostoma (82.0 ± 2.0%) was decreased when compared to the first experiment, but still greater than that of A. ingens (64.5 ± 9.5%). The competitive potential of A. ingens, however, increased significatively, demonstrating the influence of its previous colonization in the media for achieving a higher viability. In both experiments the competitive potential of P. chrysostoma was greater and similar to observations cited in the literature. Control-groups of each species were observed, individually, for the comparison. The mean value obtained for P. chrysostoma was 94.0 ± 3.7% (0.0% [experiment 1] and only 12.8% [experiment 2] greater than the average competitive factor). For A. ingens the average was 86.0 ± 7.3% (64.0% [experiment 1] and 25.0% [experiment 2] greater than average competitive factor)
In both species, maintained under laboratory environmental conditions, anautogeny was comproved and all females that had free access to proteic source were fertiles. We obtained the following average values for Peckiachrysostoma: 59.7 ± 15.6 and 81.8 ± 15.4 days of longevity in the respective cases of free access and no access to proteic source, 21.4 ± 4.3 days of pre-larviposition period and 35.2 ± 16.5 days of larviposition period, 5.3 ± 1.8 larvipositions female with 7.0 ± 1.1 days of periodicity, 35.7 ± 6.1 larvae per larviposition leading to a total number of 183.8 ± 69.2 viable larvae per female and 94.8% ± 5.3% of productivity. The mean number of ovarioles per female was 56.4 ± 9.8, resulting in a reproductive potential of 63.3%. For Adiscochaeta ingens, the obtained average values were: 41.3 ± 6.3 and 52 ± 13.1 days of longevity in the respective cases of free access and no access to proteic source, 15.3 ± 1.7 days of pre-larviposition period and 21.5 ± 7.5 days of larviposition period, 3 ± 0.7 larvipositions per female with 10.4 ± 0.8 days of periodicity, 30.3 ± 8.2 larvae per larviposition leading to a total number of 78.5 ± 21.7 viable larvae per female and 90.1% ± 16% of productivity. The mean number of ovarioles per female was 54.6 ± 5.2, resulting in a reproductive potential of 55.5%. Within applied parameters, the values obtained for P. chrysostoma demonstrate its superior productivity in comparison with A. ingen
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.